CALLI BERMAN: Open Payments
NPI 1609363431 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 32 payments from 7 companies in 2025. Trend: 2023 $393 · 2024 $395 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $166 |
| Indivior Inc. | 3 | $91 |
| Orexo US, Inc. | 2 | $44 |
| Braeburn Inc. | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: CAPLYTA, MAVYRET, SUBLOCADE, VRAYLAR, Zubsolv, BRIXADI, REXULTI, Auvelity.
Industry payments across MI — which companies pay providers there.
